Send to

Choose Destination
Curr Res Diabetes Obes J. 2017 Jun;2(3). pii: 555587. Epub 2017 Jun 5.

Impaired Cerebral Autoregulation-A Common Neurovascular Pathway in Diabetes may Play a Critical Role in Diabetes-Related Alzheimer's Disease.

Author information

Department of Neurology, University of Mississippi Medical Center, USA.
Institute of Clinical Medicine, University of Turku, Finland.
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, USA.
Department of Urology, Fudan University, China.
Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, China.


Alzheimer's disease (AD) is the leading cause of progressive degenerative dementia. The hallmark pathological features include beta amyloid deposition and neurofibrillary tangles. There has been a strong association of AD with Diabetes (DM) based on human studies and animal experiments. The hallmark features of AD seem to have an exaggerated presence in AD with DM, especially type 2 diabetes (T2D). In addition, insulin resistance is a common feature in both diseases and as such AD has been called type 3 diabetes. Furthermore, impairment of cerebral autoregulation has been reported in both animal and human diabetic subjects. Cerebral vascular impairment has also been implicated in the pathophysiology of AD. There is an urgent need to develop animal models of AD and DM to explore the neuropathological mechanisms of these disease and utilize such models to develop treatment strategies.


Alzheimer’s; Autoregulation; Dementia; Diabetes; Myogenic response; Rat model; T2DN


Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center